Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Troubles cognitifs, syndrome extrapyramidal et hyperammoniémie sous traitement thymorégulateur par divalproate de sodium : à propos d’un cas. Local targets link to admitted publications; unresolved targets remain external evidence.
Parkinsonian syndrome in childhood after sodium valproate administration
10.1097/00002826-199310000-00009 · 1993 · External reference
Reversible parkinsonism and cognitive impairment with chronic valproate use
10.1212/wnl.47.3.626 · 1996 · External reference
Reversible parkinsonism induced by prolonged treatment with valproate (Syndrome parkinsonien réversible secondaire à la prise de valproate au long cours)
2002 · External reference
Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy
10.1111/j.1553-2712.2001.tb01102.x · 2001 · External reference
Fulminant progression of demyelinating disease after valproate-induced encephalopathy
10.1212/wnl.51.1.292 · 1998 · External reference
Valproate induced-encephalopathy
2001 · External reference
Valproate-induced coma : case report and literature review
10.1177/106002809302700510 · 1993 · External reference
Ammonia induced encephalopathy from valproic acid in a bipolar patient : case report
10.2190/xw8e-q283-4429-ql71 · 2003 · External reference
Hyperammonemia and coma developed by a woman treated with valproic acid for affective disorder
10.1176/ps.49.10.1358 · 1998 · External reference
Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment
10.1111/j.1528-1157.1998.tb01270.x · 1998 · External reference
Valproate tremors
10.1212/wnl.32.4.428 · 1982 · External reference
Is 2-propyl-4-pentenoic acid, a hepatotoxic metabolite of valproate, responsible for valproate-induced hyperammonemia ?
10.1111/j.1528-1157.1992.tb01708.x · 1992 · External reference
Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient
10.1016/s0196-0644(05)81955-9 · 1993 · External reference
A case of severe hyperammonemia and unconsciousness following sodium valproate intoxication
1998 · External reference
Dementia and extrapyramidal problems caused by long-term valproic acid
2000 · External reference
A case report of valproate encephalopathy
1999 · External reference
Reversible parkinsonism induced by prolonged treatment with valproate
10.1007/s004150050288 · 1998 · External reference
Hyperammonemic encephalopathy associated with valproate acid
2003 · External reference
Reversible dementia and apparent brain atrophy during valproate therapy
10.1002/ana.410380423 · 1995 · External reference
Valproate induced parkinsonism
1998 · External reference
Parkinsonism induced by sodium valproate
1995 · External reference
Reversible valproate-induced extrapyramidal disorders
10.1111/j.1528-1157.1994.tb02449.x · 1994 · External reference
Drug-induced parkinsonism
10.1097/00127893-200211000-00006 · 2002 · External reference
Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs
10.1007/s005990050060 · 1999 · External reference
Valproate-induced hyperammonemic encephalopathy
10.1023/a:1021918104127 · 2002 · External reference
Reversible valproic acid-induced dementia : a case report
10.1111/j.1528-1157.1986.tb03534.x · 1986 · External reference
